TrianglePUBLICATIONS · 34363762
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2021 Sep
- First author
- Monk BJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Monk BJ
- type
- Author
- name
- Colombo N
- type
- Author
- name
- Oza AM
- type
- Author
- name
- Fujiwara K
- type
- Author
- name
- Birrer MJ
- type
- Author
- name
- Randall L
- type
- Author
- name
- Poddubskaya EV
- type
- Author
- name
- Scambia G
- type
- Author
- name
- Shparyk YV
- type
- Author
- name
- Lim MC
- type
- Author
- name
- Bhoola SM
- type
- Author
- name
- Sohn J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Monk BJ
- type
- Author
- name
- Colombo N
- type
- Author
- name
- Oza AM
- type
- Author
- name
- Fujiwara K
- type
- Author
- name
- Birrer MJ
- type
- Author
- name
- Randall L
- type
- Author
- name
- Poddubskaya EV
- type
- Author
- name
- Scambia G
- type
- Author
- name
- Shparyk YV
- type
- Author
- name
- Lim MC
- type
- Author
- name
- Bhoola SM
- type
- Author
- name
- Sohn J
- type
- Author
- bibliography ids
- nci-bib-1f6723f2849cdf99157b153f
- book metadata
- content sha256
- e101d3b54013acfdcf22080f7fb1a5d87f84897712a3bc548eeafa1c7541020a
- document type
- citation
- dois
- 10.1016/S1470-2045(21)00342-9
- electronic publication date
- display
- 2021 Aug 4
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34363762
- immutable id
- pubmed:34363762@e101d3b54013acfdcf22080f7fb1a5d87f84897712a3bc548eeafa1c7541020a
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 9
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1275-1289
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34363762
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- 3b7f98c730aea3d9e3a134fbf270ee266625dc414fda4e00aa5dedb72a712ea6
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Sep
- precision
- month
- year
- 2021
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Preserved source evidence · Not medical advice